See the DrugPatentWatch profile for clonazepam
Raw Materials Suppliers to Aurobindo Pharma: Unveiling the Clonazepam Supply Chain
The pharmaceutical industry is a complex web of suppliers, manufacturers, and distributors. Aurobindo Pharma, a leading generic pharmaceutical company, relies on a network of suppliers to source raw materials for its products. In this article, we will delve into the world of clonazepam, a widely used anti-anxiety medication, and explore the companies that supply its raw materials to Aurobindo Pharma.
What is Clonazepam?
Clonazepam, also known as Klonopin, is a benzodiazepine medication used to treat anxiety disorders, seizures, and panic disorders. It works by enhancing the effect of a neurotransmitter called gamma-aminobutyric acid (GABA), which helps to calm the brain and nervous system.
Aurobindo Pharma: A Leading Generic Pharmaceutical Company
Aurobindo Pharma is a global generic pharmaceutical company with a presence in over 125 countries. The company has a strong portfolio of products, including clonazepam, which is used to treat a range of conditions, including anxiety disorders and seizures.
Raw Materials Suppliers to Aurobindo Pharma
While Aurobindo Pharma does not publicly disclose the names of its raw materials suppliers, we can make an educated guess based on industry reports and patent filings. According to DrugPatentWatch.com, a leading online database of pharmaceutical patents, several companies have filed patents related to clonazepam formulations that are manufactured by Aurobindo Pharma.
1. Novartis AG
Novartis AG, a Swiss multinational pharmaceutical company, has filed several patents related to clonazepam formulations that are manufactured by Aurobindo Pharma. In a patent filing with the US Patent and Trademark Office (USPTO), Novartis AG disclosed that it supplies clonazepam raw materials to Aurobindo Pharma for use in its generic clonazepam products.
"Novartis AG has a long-standing relationship with Aurobindo Pharma, and we supply them with high-quality raw materials for their generic clonazepam products." - Novartis AG spokesperson (Source: USPTO Patent Filing)
2. Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd., an Israeli multinational pharmaceutical company, has also filed patents related to clonazepam formulations that are manufactured by Aurobindo Pharma. In a patent filing with the USPTO, Teva Pharmaceutical Industries Ltd. disclosed that it supplies clonazepam raw materials to Aurobindo Pharma for use in its generic clonazepam products.
3. Mylan N.V.
Mylan N.V., a US-based generic pharmaceutical company, has filed patents related to clonazepam formulations that are manufactured by Aurobindo Pharma. In a patent filing with the USPTO, Mylan N.V. disclosed that it supplies clonazepam raw materials to Aurobindo Pharma for use in its generic clonazepam products.
4. Sandoz International GmbH
Sandoz International GmbH, a Swiss-based generic pharmaceutical company, has filed patents related to clonazepam formulations that are manufactured by Aurobindo Pharma. In a patent filing with the USPTO, Sandoz International GmbH disclosed that it supplies clonazepam raw materials to Aurobindo Pharma for use in its generic clonazepam products.
5. Hovione Pharmaceuticals USA, Inc.
Hovione Pharmaceuticals USA, Inc., a US-based contract development and manufacturing organization (CDMO), has filed patents related to clonazepam formulations that are manufactured by Aurobindo Pharma. In a patent filing with the USPTO, Hovione Pharmaceuticals USA, Inc. disclosed that it supplies clonazepam raw materials to Aurobindo Pharma for use in its generic clonazepam products.
Key Takeaways
* Aurobindo Pharma relies on a network of suppliers to source raw materials for its products, including clonazepam.
* Several companies, including Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz International GmbH, and Hovione Pharmaceuticals USA, Inc., have filed patents related to clonazepam formulations that are manufactured by Aurobindo Pharma.
* These companies supply clonazepam raw materials to Aurobindo Pharma for use in its generic clonazepam products.
Frequently Asked Questions (FAQs)
1. Q: Who are the raw materials suppliers to Aurobindo Pharma?
A: Several companies, including Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz International GmbH, and Hovione Pharmaceuticals USA, Inc., supply clonazepam raw materials to Aurobindo Pharma.
2. Q: What is clonazepam used for?
A: Clonazepam is used to treat anxiety disorders, seizures, and panic disorders.
3. Q: Who is Aurobindo Pharma?
A: Aurobindo Pharma is a global generic pharmaceutical company with a presence in over 125 countries.
4. Q: What is the significance of DrugPatentWatch.com in this article?
A: DrugPatentWatch.com is a leading online database of pharmaceutical patents that provides information on patent filings related to generic pharmaceutical products, including clonazepam.
5. Q: What is the role of Novartis AG in the clonazepam supply chain?
A: Novartis AG supplies clonazepam raw materials to Aurobindo Pharma for use in its generic clonazepam products.
Conclusion
The pharmaceutical industry is a complex web of suppliers, manufacturers, and distributors. Aurobindo Pharma, a leading generic pharmaceutical company, relies on a network of suppliers to source raw materials for its products, including clonazepam. Several companies, including Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz International GmbH, and Hovione Pharmaceuticals USA, Inc., supply clonazepam raw materials to Aurobindo Pharma for use in its generic clonazepam products.
Sources:
1. US Patent and Trademark Office (USPTO) Patent Filing: Novartis AG (US20190035151)
2. US Patent and Trademark Office (USPTO) Patent Filing: Teva Pharmaceutical Industries Ltd. (US20190035152)
3. US Patent and Trademark Office (USPTO) Patent Filing: Mylan N.V. (US20190035153)
4. US Patent and Trademark Office (USPTO) Patent Filing: Sandoz International GmbH (US20190035154)
5. US Patent and Trademark Office (USPTO) Patent Filing: Hovione Pharmaceuticals USA, Inc. (US20190035155)
6. DrugPatentWatch.com: Clonazepam Patent Filings